Red-Blue Light Therapy Mitigates Atopic Dermatitis via CD56bright NK Cell Modulation: A Mendelian Randomization Study
{{output}}
Objectives: This study investigates the role of the CD56bright NK cell subpopulation, cytokine levels, and the effectiveness of red-blue light therapy in elderly patients with Atopic Dermatitis (AD) using Mendelian Randomization ... ...
